Studies on the influence of pH and pancreatin on 13C-formaldehyde- induced gelatin cross-links using nuclear magnetic resonance

Pharmaceutical Development and Technology

Volumn 1, Issue 1, 1996, Pages 21-26

  Gold, Thomas B ^a   Smith, Stanford L ^b   Digenis, George A ^a  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cross linking; Dissolution; Formaldehyde; Gelatin; Nuclear magnetic resonance; Pancreatin

Indexed keywords

ARGININE DERIVATIVE; CARBON 13; FORMALDEHYDE; GELATIN; LYSINE DERIVATIVE; METHANOL DERIVATIVE; PANCREATIN; POLYARGININE; POLYLYSINE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; PH; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION;

EID: 0030317438     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459609031414     Document Type: Article

References (23)

1. G. A. Digenis, T. B. Gold, and V. P. Shah, Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance, J. Pharm. Sci., 83(7), 915-921 (1994).
2. B. E. Jones, History of the hard gelatin capsule, in Hard Capsules - Development and Technology, (K. Ridgeway, ed.), The Pharmaceutical Press, London, 1987, pp. 2-19, 39-48.
3. B. T. Palemo and S. C. McMillion, Method of treating gelatin capsules and product resulting therefrom, U.S. Patent 2,578,943, 1951.
4. E. A. Swinyard and W. Lowenthal, Pharmaceutical necessities, Remington's Pharmaceutical Sciences, 18th ed. (A. R. Gennaro, ed.). Mack, Eaton, PA, 1990, p. 1306.
5. J. R. Schwier, G. G. Cooke, K. J. Hartauer, and L. Yu, Rayon, A source of furfural - a reactive aldehyde capable of insolubilizing gelatin capsules, Pharm. Tech., 17(5), 78-79 (1993).
6. E. Doelker and A. C. Vial-Bernasconi, Interactions contenant-contenu au sein des capsules gélatineuses et évaluation critique de leurs effects sur la disponibilité des principes actifs, STP Pharma., 4(4), 298-306 (1988).
7. H. Mohamad, R. Renoux, S. Aiache, and J.-M. Aiache, Etude de la stabilité biopharmaceutique des médicaments: application à des gélules de chlorohydrate de tétracycline I. Etude in vitro, STP Pharma., 2(17), 531-535 (1986).
8. H. Mohamad, R. Renoux, S. Aiache, J.-M. Aiache, and J.-P Kantelip, Etude de la stabilité biopharmaceutique des médicaments: application à des gélules de chlorhydrate de tétracycline II. Etude in vivo, STP Pharma., 2(18), 630-635 (1986).
9. H. Mohamad, J.-M. Aiache, R. Renoux, P. Mougin, and J.-P. Kantelip, Etude de la stabilité biopharmaceutique des médicaments: application à des gélules de chlorhydrate de tétracycline IV. Etude complémentaire in vivo, STP Pharma., 3(5), 407-411 (1987).
10. A. Martin, Anti-infective agents, in Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 9th ed. (J.N. Delgado and W.A. Remers, eds.), J.B. Lippincott, New York, 1991, p. 157.
11. S. K. Taylor, F. Davidson, and D. W. Ovenall, Carbon-13 nuclear magnetic resonance studies on gelatin crosslinking by formaldehyde, Photogr. Sci. Eng., 22(3), 1433-1436 (1978).
12. 13C NMR study, Z. Naturforsch, 41b(3), 351-358 (1986).
13. 13C NMR spectroscopy, Z. Naturforsch, 46b(3), 385-389 (1991).
14. G. C. Levy and G. L. Nelson, Carbon-13 Nuclear Magnetic Resonance for Organic Chemists, Wiley-Interscience, New York, 1972, pp. 1-31, 157-158, 161-172.
15. C. Walsh, Enzymatic Reaction Mechanisms, W. H. Freeman, San Francisco, 1979, pp. 53-55, 98-104.
16. K. S. Murthy, R. G. Reisch, Jr., and M. B. Fawzi, Dissolution stability of hard-shell capsule products. Part II: The effect of dissolution test conditions on in vitro drug release, Pharm. Technol., 13(6), 53-58 (1989).
17. T. C. Dahl, I-L. T. Sue, and A. Yum, The effect of pancreatin on the dissolution performance of gelatin-coated tablets exposed to high-humidity conditions, Pharm. Res., 8(3), 412-414 (1991).
18. M. Dey, R. Enever, M. Kraml, D.G. Prue, D. Smith, and R. Weierstall, The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures, Pharm. Res., 10(9), 1295-1300 (1993).
19. G. A. Digenis and T. B. Gold, Chemistry of gelatin cross-linking, Pharm. Res., 11(10), S146, PT 6064 (1994).
20. G. D. Fasman, Practical Handbook of Biochemistry and Molecular Biology, CRC Press, Boston, 1989, pp.13, 25.
21. M. Kobayashi, S. Matsura, T. Sato, and H. Yamada, Preparation of capsules from succinylated gelatins, Japan. Patent 61/186314 A2, 1986.
22. T. Sato, H. Yamada, M. Kobayashi, and S. Matsura, Succinylated gelatin capsules for aldehyde containing antibiotics. Japan. Patent 61/186315 A2, 1986.
23. P. Buri, C. Mikler, and P. Barthelemy, Pharmaceutical gelatin capsules containing ammonium compounds or sulfides to prevent tanning by the encapsulated material, especially fenofibrate, French Patent 2617047, 1988.